Literature DB >> 2463375

The hepatitis B virus-associated reverse transcriptase is encoded by the viral pol gene.

M Bavand1, M Feitelson, O Laub.   

Abstract

We have used activity gel analysis and immunoblotting to provide evidence linking the hepatitis B virus (HBV) reverse transcriptase with its longest unassigned open reading frame (polymerase [Pol]-ORF). Activity gel analysis demonstrated that infectious HBV particles secreted by the Hep 2.2.15 cell line contain major (approximately 70 kilodaltons [kDa]) and minor (approximately 90 kDa) reverse transcriptase activities. By Western immunoblotting, we detected in both HBV particles and Hep 2.2.15 cell extract a approximately 70-kDa Pol-specific peptide. This approximately 70-kDa peptide reacted with antisera directed against the carboxy terminus of the pol gene product. No such immunoreactivity was observed with antisera against the amino terminus of the Pol peptide. The reverse transcriptase protein which was eluted from the major approximately 70-kDa region detected on an activity gel reacted with Pol-specific antisera. Furthermore, reverse transcriptase activity was immunoprecipitated from dissociated HBV particles by using Pol-specific antisera. On the basis of our results, we suggest that HBV encodes its reverse transcriptase from the Pol-ORF.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2463375      PMCID: PMC247788     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  12 in total

1.  Two proteins with reverse transcriptase activities associated with hepatitis B virus-like particles.

Authors:  M R Bavand; O Laub
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

2.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.

Authors:  D S Dane; C H Cameron; M Briggs
Journal:  Lancet       Date:  1970-04-04       Impact factor: 79.321

3.  A chronic carrierlike state is established in nude mice injected with cloned hepatitis B virus DNA.

Authors:  M A Feitelson; L J DeTolla; X D Zhou
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

4.  Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.

Authors:  J Summers; W S Mason
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

Review 5.  Persistent infection of humans with hepatitis B virus: mechanisms and consequences.

Authors:  D Ganem
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

6.  Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

Authors:  M A Sells; M L Chen; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

7.  DNA polymerase associated with human hepatitis B antigen.

Authors:  P M Kaplan; R L Greenman; J L Gerin; R H Purcell; W S Robinson
Journal:  J Virol       Date:  1973-11       Impact factor: 5.103

8.  Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees.

Authors:  G Acs; M A Sells; R H Purcell; P Price; R Engle; M Shapiro; H Popper
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

9.  Synthesis of hepatitis B surface antigen in mammalian cells: expression of the entire gene and the coding region.

Authors:  O Laub; L B Rall; M Truett; Y Shaul; D N Standring; P Valenzuela; W J Rutter
Journal:  J Virol       Date:  1983-10       Impact factor: 5.103

10.  Hepatitis B viral DNA-RNA hybrid molecules in particles from infected liver are converted to viral DNA molecules during an endogenous DNA polymerase reaction.

Authors:  R H Miller; P L Marion; W S Robinson
Journal:  Virology       Date:  1984-11       Impact factor: 3.616

View more
  12 in total

1.  Evidence that less-than-full-length pol gene products are functional in hepadnavirus DNA synthesis.

Authors:  T T Wu; L D Condreay; L Coates; C Aldrich; W Mason
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity.

Authors:  G Radziwill; W Tucker; H Schaller
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

3.  Internal entry of ribosomes and ribosomal scanning involved in hepatitis B virus P gene expression.

Authors:  O Jean-Jean; T Weimer; A M de Recondo; H Will; J M Rossignol
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

4.  A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency.

Authors:  X Lin; Z H Yuan; L Wu; J P Ding; Y M Wen
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Reverse transcriptase encoded by a retrotransposon from the trypanosomatid Crithidia fasciculata.

Authors:  A Gabriel; J D Boeke
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

6.  Differentiation-specific transcriptional regulation of the hepatitis B virus large surface antigen gene in human hepatoma cell lines.

Authors:  A K Raney; D R Milich; A J Easton; A McLachlan
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

7.  Detection of an RNase H activity associated with hepadnaviruses.

Authors:  S M Oberhaus; J E Newbold
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

8.  Expression of the P-protein of the human hepatitis B virus in a vaccinia virus system and detection of the nucleocapsid-associated P-gene product by radiolabelling at newly introduced phosphorylation sites.

Authors:  R Bartenschlager; C Kuhn; H Schaller
Journal:  Nucleic Acids Res       Date:  1992-01-25       Impact factor: 16.971

Review 9.  Hepatitis B virus infection and primary hepatocellular carcinoma.

Authors:  M Feitelson
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

10.  Detection of DNA polymerase activities associated with purified duck hepatitis B virus core particles by using an activity gel assay.

Authors:  S M Oberhaus; J E Newbold
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.